We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience. You can read our Cookie Policy here.


Gemini Bio Announces Dedicated Support for COVID-19 Research

Gemini Bio Announces Dedicated Support for COVID-19 Research content piece image

Want a FREE PDF version of this product news?

Complete the form below and we will email you a PDF version of "Gemini Bio Announces Dedicated Support for COVID-19 Research"

Listen with
Register for free to listen to this article
Thank you. Listen to this article using the player above.
Read time:

Gemini Bioproducts, LLC (Gemini Bio), a supplier of cell culture solutions, has announced its effort to help support COVID-19 research.

To support labs pivoting to COVID-19 research, Gemini Bio is prioritizing products and services to assist its customers in four key areas: cell culture, viral harvesting and transport, research tools, and analytical instruments.

Moxi Go II, an analytical instrument

Gemini carries gold-standard cell and protein analysis instrumentation through its line of Moxi products. The Moxi Go has the potential to enable simultaneous, rapid analysis of antibodies and cytokines tied to COVID-19. The Moxi Go uniquely combines highly accurate and precise cell counting and volumetric sizing with the cell and protein analysis capabilities of a flow cytometer.

The Moxi Go instrument is differentiated by its accuracy, its small footprint for easy deployment, its speed – with tests running in less than 20 seconds – and its ability to calibrate every test independently. The instrument has a touchscreen for easy, intuitive use so that technicians will be able to easily navigate the system menus. Moreover, the instrument is fully self-contained, requiring no cleaning fluids or maintenance, making it ideal for cell culture suites, BSL2/3/4 settings with limited space.